TY - JOUR
KW - COVID-19
KW - Female
KW - Health Services Accessibility
KW - Humans
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pandemics
KW - Pregnancy
KW - SARS-CoV-2
KW - Substance-Related Disorders/epidemiology
KW - Telemedicine
KW - Alcohol
KW - opioid use disorder
KW - Pandemic
KW - Postpartum
KW - Substance use disorder
AU - H. E. Jones
AU - E. Hairston
AU - A. C. Lensch
AU - L. K. Marcus
AU - S. H. Heil
A1 - 
AD - UNC Horizons, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America. Electronic address: Hendree_Jones@med.unc.edu.; UNC Horizons, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.; Choate Rosemary Hall, Wallingford, CT, United States of America.; VCU /Institute of Drug and Alcohol Studies mid Departent of Psychiatry, Virginia Commonwealth University, Richmond, VA, United States of America.; Vermont Center Behavior and Health Departments of Psychiatry and Psychological Science, University of Vermont, Burlington, VT, United States of America.
BT - Preventive medicine
C5 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
CP - Pt 2
DO - 10.1016/j.ypmed.2021.106742
IS - Pt 2
JF - Preventive medicine
LA - eng
M1 - Journal Article
PB - Elsevier Inc
PY - 2021
SN - 1096-0260; 0091-7435; 0091-7435
SP - 106742
T1 - Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period
T2 - Preventive medicine
TI - Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period
U1 - Healthcare Disparities; HIT & Telehealth; Opioids & Substance Use
U2 - 34302836
U3 - 10.1016/j.ypmed.2021.106742
VL - 152
VO - 1096-0260; 0091-7435; 0091-7435
Y1 - 2021
Y2 - Nov
ER -